GBI Research Reports
GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.
Search GBI Research Reports
Latest Reports from GBI Research Reports
| |||||||||||||||||||||||
| Name | Date | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COPD Therapeutics in Major Developed Markets to 2021 - Emergence of Addition-in-Class and First-in-Class Products Offsets Sales Erosion of Leading Brands | Nov 13, 2015 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS COPD Therapeutics in Major Developed Markets to #### Emergence of Addition-in- Class and First-in-Class Products Offsets Sales Erosion of Leading Brands Published: November #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a... | |||||||||||||||||||||||
| Prostate Cancer Market to 2021 - Increasing Disease Prevalence to be a Key Driver of Market Growth | Nov 01, 2015 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Prostate Cancer Market to #### - Increasing Disease Prevalence to be a Key Driver of Market Growth Published: November #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied... | |||||||||||||||||||||||
| Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations | Nov 01, 2015 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Type # Diabetes Mellitus Therapeutics in Major Developed Markets to #### - Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations Published: November #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product... | |||||||||||||||||||||||
| Frontier Pharma: Obesity - Identifying and Commercializing First-in-Class Innovation | Oct 01, 2015 | ||||||||||||||||||||||
| ...FRONTIER PHARMA Obesity - Identifying and Commercializing First-in- Class Innovation Published: October #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied [Front cover image reference: Brown adipocytes stained with... | |||||||||||||||||||||||
| Multiple Myeloma Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Velcade, Revlimid and Emerging Supplementary Treatments | Oct 01, 2015 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Multiple Myeloma Therapeutics in Asia-Pacific Markets to #### - Growth Driven by Rising Prevalence, Continued Success of Velcade, Revlimid and Emerging Supplementary Treatments Report Code: GBIHC###MR Published: October #### www.gbiresearch.com © GBI Research. This is a licensed... | |||||||||||||||||||||||
| Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line | Sep 01, 2015 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to #### - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line Report Code: GBIHC###MR Published: September #### www.gbiresearch.com © GBI Research. This is a... | |||||||||||||||||||||||
| Hepatitis B Therapeutics in Major Developed Markets to 2021 - Increasing Number of Migrants from High-Prevalence Regions to Drive Market Growth | Sep 01, 2015 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Hepatitis B Therapeutics in Major Developed Markets to #### Increasing Number of Migrants from High-Prevalence Regions to Drive Market Growth Report Code: GBIHC###MR Published: September #### www.gbiresearch.com © GBI Research. This is a licensed product and... | |||||||||||||||||||||||
| Frontier Pharma: Innovative Licensing Opportunities in Non-Hodgkin Lymphoma | Aug 06, 2015 | ||||||||||||||||||||||
| ...FRONTIER PHARMA Innovative Licensing Opportunities in Non-Hodgkin Lymphoma Published: August #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied [Front cover image: non-Hodgkin lymphoma, NCI Center for... | |||||||||||||||||||||||
| Type 2 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Strong Pipeline and Expanding Treatment Population to Encourage Robust Growth | Jul 03, 2015 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Type # Diabetes Mellitus Therapeutics in Major Developed Markets to #### - Strong Pipeline and Expanding Treatment Population to Encourage Robust Growth Report Code: GBIHC###MR Published: July, #### www.gbiresearch.com © GBI Research. This is a licensed product and... | |||||||||||||||||||||||
| Multiple Myeloma Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments | Jul 01, 2015 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Multiple Myeloma Therapeutics in Major Developed Markets to #### - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments Report Code: GBIHC###MR Published: July #### www.gbiresearch.com © GBI Research. This is a licensed product... | |||||||||||||||||||||||
| Frontier Pharma: Versatile Innovation in Oncology - Identifying and Commercializing Versatile First-in-Class Innovation | Jul 01, 2015 | ||||||||||||||||||||||
| ...FRONTIER PHARMA Versatile Innovation in Oncology - Identifying and Commercializing Versatile First-in-Class Innovation Published: July #### Report Code: GBIHC###MR www.gbiresearch.com © GBI Research. This is a licensed product and is not to be photocopied [Front cover image: Emerging... | |||||||||||||||||||||||
| Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2021 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline | Jul 01, 2015 | ||||||||||||||||||||||
| ...THERAPY ANALYSIS Anti-hypertensive Therapeutics in Asia-Pacific Markets to #### - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline Report Code: GBIHC###MR Published: July #### www.gbiresearch.com © GBI Research. This is a licensed product and is not... | |||||||||||||||||||||||
| Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation | Jun 01, 2015 | ||||||||||||||||||||||
| Frontier Pharma: Duchenne Muscular Dystrophy and Becker Muscular Dystrophy - Identifying and Commercializing First-in-Class Innovation | May 01, 2015 | ||||||||||||||||||||||
| Psoriasis Therapeutics in Asia-Pacific Markets to 2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth | May 01, 2015 | ||||||||||||||||||||||
| Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation | May 01, 2015 | ||||||||||||||||||||||
| Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs | May 01, 2015 | ||||||||||||||||||||||
| MRI Systems Market to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies | Apr 02, 2015 | ||||||||||||||||||||||
| Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 - Asia-Pacific | Apr 01, 2015 | ||||||||||||||||||||||
| Market Digest: Ultrasound Systems Market 2006 to 2020 - Americas | Mar 09, 2015 | ||||||||||||||||||||||
| ...Ultrasound Systems Market #### to #### Americas Published: GBIME###MS Report Code: March #### www.gbiresearch.com MARKET DIGEST © GBI Research. This is a licensed product and is not to be photocopied GBIME###MS / Published Mar #### Page # # Table of... | |||||||||||||||||||||||
